MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Total Assets (Quarterly): 157.41M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 157.41M |
June 30, 2024 | 130.86M |
March 31, 2024 | 121.74M |
December 31, 2023 | 129.13M |
September 30, 2023 | 135.73M |
June 30, 2023 | 142.54M |
March 31, 2023 | 150.79M |
December 31, 2022 | 119.14M |
September 30, 2022 | 122.57M |
June 30, 2022 | 58.51M |
December 31, 2021 | 75.07M |
June 30, 2021 | 46.38M |
June 30, 2021 | 46.38M |
December 31, 2020 | 31.86M |
June 30, 2020 | 39.86M |
June 30, 2020 | 39.86M |
December 31, 2019 | 40.63M |
June 30, 2019 | 49.88M |
June 30, 2019 | 49.88M |
December 31, 2018 | 65.48M |
June 30, 2018 | 83.20M |
June 30, 2018 | 83.20M |
December 31, 2017 | 58.52M |
Date | Value |
---|---|
June 30, 2017 | 66.66M |
June 30, 2017 | 66.66M |
December 31, 2016 | 67.72M |
June 30, 2016 | 50.39M |
June 30, 2016 | 50.39M |
December 31, 2015 | 57.74M |
June 30, 2015 | 55.16M |
June 30, 2015 | 55.16M |
December 31, 2014 | 30.95M |
June 30, 2014 | 21.38M |
June 30, 2014 | 21.38M |
December 31, 2013 | 29.38M |
June 30, 2013 | 35.31M |
June 30, 2013 | 35.31M |
December 31, 2012 | 19.95M |
June 30, 2012 | 13.33M |
June 30, 2012 | 13.33M |
December 31, 2011 | 19.01M |
June 30, 2011 | 25.87M |
December 31, 2010 | 19.18M |
June 30, 2010 | 22.69M |
December 31, 2009 | 35.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.86M
Minimum
Dec 2020
157.41M
Maximum
Sep 2024
93.44M
Average
119.14M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
Galapagos NV | 4.660B |
UCB SA | 16.75B |
Mithra Pharmaceuticals SA | 407.25M |
Nyxoah SA | 159.45M |
Celyad Oncology SA | 13.23M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 140.41M |
Shareholders Equity (Quarterly) | 16.99M |
Debt to Equity Ratio | 3.022 |
Current Ratio | 1.541 |
Net Debt Paydown Yield | -3.16% |